WallStreetZenWallStreetZen

NASDAQ: ABEO
Abeona Therapeutics Inc Earnings & Revenue

ABEO past revenue growth

How has ABEO's revenue growth performed historically?
Company
227.72%
Industry
82.81%
Market
19.67%
ABEO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ABEO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ABEO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ABEO earnings and revenue history

Current Revenue
$3.5M
Current Earnings
-$76.7M
Current Profit Margin
-2,190.3%

ABEO Return on Equity

Current Company
-821.5%
Current Industry
16.8%
Current Market
28.2%
ABEO's Return on Equity (-821.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ABEO announces earnings.

ABEO Return on Assets

Current Company
-118.6%
Current Industry
3.2%
ABEO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ABEO Return on Capital Employed

Current Company
-119.78%
Current Industry
-42.4%
ABEO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABEO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ABEO$3.50M-$72.36M-$76.66M+7.25%N/A
BMEA$0.00-$122.55M-$127.27MN/AN/A
TRVI$0.00-$33.30M-$33.57MN/AN/A
AKBA$187.23M$7.34M-$43.03M-4.40%N/A
DSGN$0.00-$58.10M-$58.67M-100.00%N/A

ABEO earnings dates

Next earnings date
Aug 6, 2024

Abeona Therapeutics Earnings & Revenue FAQ

What were ABEO's earnings last quarter?

On Invalid Date, Abeona Therapeutics (NASDAQ: ABEO) reported Q1 2024 earnings per share (EPS) of -$1.16, up 114.81% year over year. Total Abeona Therapeutics earnings for the quarter were -$31.58 million. In the same quarter last year, Abeona Therapeutics's earnings per share (EPS) was -$0.54.

If you're new to stock investing, here's how to buy Abeona Therapeutics stock.

What was ABEO's earnings growth in the past year?

As of Q2 2024, Abeona Therapeutics's earnings has grown year over year. Abeona Therapeutics's earnings in the past year totalled -$76.66 million.

What is ABEO's earnings date?

Abeona Therapeutics's earnings date is Invalid Date. Add ABEO to your watchlist to be reminded of ABEO's next earnings announcement.

What was ABEO's revenue last quarter?

On Invalid Date, Abeona Therapeutics (NASDAQ: ABEO) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Abeona Therapeutics's revenue was $0.00.

What was ABEO's revenue growth in the past year?

As of Q2 2024, Abeona Therapeutics's revenue has grown 227.72% year over year. This is 144.91 percentage points higher than the US Biotechnology industry revenue growth rate of 82.81%. Abeona Therapeutics's revenue in the past year totalled $3.50 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.